HRs |
hormone receptors |
ER |
estrogen receptor |
PR |
progesterone receptor |
HER2 |
human epidermal growth factor 2 |
RT |
radiotherapy |
LB |
liquid biopsies |
CTCs |
circulating tumor cells |
ctDNA |
cell-free circulating tumor DNA |
EpCAM |
epithelial cell adhesion molecule |
EVs |
extracellular vesicles |
cfDNA |
cell-free DNA |
RT-qPCR |
real-time quantitative PCR |
WGS |
whole-genome sequencing |
WES |
whole-exome sequencing |
MAFs |
mutant allele frequencies |
ddPCR |
digital droplet PCR |
Erα |
estrogen receptor alpha |
AIs |
aromatase inhibitors |
NGS |
next-generation sequencing |
SNPs |
single nucleotide polymorphisms |
TARDIS |
targeted digital sequencing |
MVBs |
multivesicular bodies |
IDC |
invasive ductal carcinoma |
DCIS |
ductal carcinoma in situ |
TME |
tumor microenvironment |
miRNAs |
microRNAs |
GSTP1 |
glutathione S-transferase P1 |
TK1 |
thymidine kinase 1 |
CDK9 |
cyclin-dependent kinase 9 |
Hsps |
heat shock proteins |
Del-1 |
developmental endothelial locus-1 |
UCH-L1 |
ubiquitin carboxyl-terminal hydrolase-L1 |
P-gp |
P-glycoprotein |
TrpC5 |
transient receptor potential channel 5 |
EMT |
epithelial-mesenchymal transition |
MBC |
metastatic breast cancer |